Observational studies confirm effectiveness of popular anticoagulants for atrial fibrillation.
Direct oral anticoagulants (DOACs) are commonly used by patients with atrial fibrillation. Observational studies have been conducted to see if the results from randomized trials are consistent with real-world use.